Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

Medicine, Internal Medicine, Pharmacotherapy +17

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†

Robert G. Knodell, Kamal G. Ishak, William C. Black et al. · Hepatology · 1981 · 3.6K citations · Full text

Medicine, Pathology, Hepatology +16

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C

Pierre Bédossa · Hepatology · 1994 · 2K citations · Full text

Medicine, Pathology, Diagnostic Pathology +16

Liver Transplantation in European Patients with the Hepatitis B Surface Antigen

Didier Samuel, R. Müller, Graeme Alexander et al. · New England Journal of Medicine · 1993 · 1.1K citations · Full text

Medicine, Immunology, Infectious Diseases +12